Optimal Postoperative Surveillance Strategies for Colorectal Cancer: A Retrospective Observational Study

被引:3
作者
Park, Min-Young [1 ]
Park, In-Ja [1 ]
Ryu, Hyo-Seon [1 ]
Jung, Jay [1 ]
Kim, Min-Sung [1 ]
Lim, Seok-Byung [1 ]
Yu, Chang-Sik [1 ]
Kim, Jin-Cheon [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Colon & Rectal Surg, Seoul 05505, South Korea
关键词
colorectal cancer; surveillance; recurrence; survival; CLINICAL-PRACTICE GUIDELINES; INTENSIVE FOLLOW-UP; CURATIVE RESECTION; COLON-CANCER; RADICAL SURGERY; RECTAL-CANCER; RECURRENCE; SURVIVAL; CT;
D O I
10.3390/cancers13143502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Optimal surveillance strategies for colorectal cancer remain undetermined, with intensive surveillance not conferring significant survival benefits. This study aimed to assess whether surveillance intensity is associated with recurrence and survival in patients with colorectal cancer. This retrospective observational study showed that, although frequent postoperative surveillance did not improve overall survival or recurrence-free survival, surveillance improved post-recurrence survival. Analysis using a recurrence risk-prediction model showed that intensive surveillance improved both post-recurrence survival and overall survival in patients who were at high risk of recurrence. Thus, intensive surveillance does not improve overall survival and recurrence-free survival but can help improve post-recurrence survival by detecting early-stage recurrence or increasing the curative resection rate. This study aimed to assess whether surveillance intensity is associated with recurrence and survival in colorectal cancer (CRC) patients. Overall, 3794 patients with pathologic stage I-III CRC who underwent radical surgery between January 2012 and December 2014 were examined. Surveillance comprised abdominopelvic computed tomography (CT) every 6 months and chest CT annually for 5 years. Patients who underwent more than and less than an average of three imaging examinations annually were assigned to the high-intensity (HI) and low-intensity (LI) groups, respectively. Demographics were similar in both groups. T and N stages were higher and perineural and lymphovascular invasion were more frequent in the HI group (p < 0.001 each). The mean overall survival (OS) was similar for both groups; however, recurrence-free survival (RFS) was longer (p < 0.001) and post-recurrence survival (PRS) was shorter (p = 0.024) in the LI group. In the multivariate analysis, surveillance intensity was associated with RFS (p < 0.001) in contrast to PRS (p = 0.731). In patients with high recurrence risk predicted using the nomogram, OS was longer in the HI group (p < 0.001). A higher imaging frequency in patients at high risk of recurrence could be expected to lead to a slight increase in PRS but does not improve OS. Therefore, rather than increasing the number of CT scans in high-risk patients, other imaging modalities or innovative approaches, such as liquid biopsy, are required.
引用
收藏
页数:12
相关论文
共 31 条
  • [11] Lee Bo In, 2012, Korean J Gastroenterol, V59, P65
  • [12] MAKELA JT, 1995, ARCH SURG-CHICAGO, V130, P1062
  • [13] A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent
    Mant, David
    Gray, Alastair
    Pugh, Sian
    Campbell, Helen
    George, Stephen
    Fuller, Alice
    Shinkins, Bethany
    Corkhill, Andrea
    Mellor, Jane
    Dixon, Elizabeth
    Little, Louisa
    Perera-Salazar, Rafael
    Primrose, John
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (32) : 1 - +
  • [14] Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
    Meyerhardt, Jeffrey A.
    Mangu, Pamela B.
    Flynn, Patrick J.
    Korde, Larissa
    Loprinzi, Charles L.
    Minsky, Bruce D.
    Petrelli, Nicholas J.
    Ryan, Kim
    Schrag, Deborah H.
    Wong, Sandra L.
    Benson, Al B., III
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) : 4465 - +
  • [15] Beware of Early Relapse in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy
    Oh, Seul-Gi
    Park, In Ja
    Seo, Ji-Hyun
    Kim, Young Il
    Lim, Seok-Byung
    Kim, Chan Wook
    Yoon, Yong Sik
    Lee, Jong Lyul
    Yu, Chang Sik
    Kim, Jin Cheon
    [J]. ANNALS OF COLOPROCTOLOGY, 2020, 36 (06) : 382 - 389
  • [16] FOLLOW-UP AFTER CURATIVE SURGERY FOR COLORECTAL-CARCINOMA - RANDOMIZED COMPARISON WITH NO FOLLOW-UP
    OHLSSON, B
    BRELAND, U
    EKBERG, H
    GRAFFNER, H
    TRANBERG, KG
    [J]. DISEASES OF THE COLON & RECTUM, 1995, 38 (06) : 619 - 626
  • [17] Role of follow-up in management of local recurrences of colorectal cancer - A prospective, randomized study
    Pietra, N
    Sarli, L
    Costi, R
    Ouchemi, C
    Grattarola, M
    Peracchia, A
    [J]. DISEASES OF THE COLON & RECTUM, 1998, 41 (09) : 1127 - 1133
  • [18] Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer The FACS Randomized Clinical Trial
    Primrose, John N.
    Perera, Rafael
    Gray, Alastair
    Rose, Peter
    Fuller, Alice
    Corkhill, Andrea
    George, Steve
    Mant, David
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (03): : 263 - 270
  • [19] Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials
    Renehan, AG
    Egger, M
    Saunders, MP
    O'Dwyer, ST
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7341): : 813 - 816
  • [20] A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma
    Rosati, G.
    Ambrosini, G.
    Barni, S.
    Andreoni, B.
    Corradini, G.
    Luchena, G.
    Daniele, B.
    Gaion, F.
    Oliverio, G.
    Duro, M.
    Martignoni, G.
    Pinna, N.
    Sozzi, P.
    Pancera, G.
    Solina, G.
    Pavia, G.
    Pignata, S.
    Johnson, F.
    Labianca, R.
    Apolone, G.
    Zaniboni, A.
    Monteforte, M.
    Negri, E.
    Torri, V.
    Mosconi, P.
    Fossati, R.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (02) : 274 - 280